1. Bot M, Van Veldhoven PP, de Jager SCA, Johnson J, Nijstad N, Van Santbrink PJ, Westra MM, Van Der Hoeven G, Gijbels MJ, Muller-Tidow C, Varga G, Tietge UJF, Kuiper J, Van Berkel TJC, Nofer JR, Bot I, Biessen EAL. Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice.
    Plos One 8.2013.
  2. Eichner S, Thoma-Uszynski S, Herrgott I, Sebald H, Debus A, Tsianakas A, Ehrchen J, Harms G, Simon M, Sunderkotter C, Bogdan C. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
    European Journal of Dermatology 23:218-223.2013.
  3. Foell D, Wittkowski H, Kessel C, Luken A, Weinhage T, Varga G, Vogl T, Wirth T, Viemann D, Bjork P, van Zoelen MAD, Gohar F, Srikrishna G, Kraft M, Roth J. Proinflammatory S100A12 Can Activate Human Monocytes via Toll-like Receptor 4.
    American Journal of Respiratory and Critical Care Medicine 187:1324-1334.2013.
  4. Friesenhagen J, Viemann D, Borgeling Y, Schmolke M, Spiekermann C, Kirschnek S, Ludwig S, Roth J. Highly Pathogenic Influenza Viruses Inhibit Inflammatory Response in Monocytes via Activation of Rar-Related Orphan Receptor ROR alpha.
    Journal of Innate Immunity 5:505-518.2013.
  5. Hildebrand DG, Alexander E, Horber S, Lehle S, Obermayer K, Munck NA, Rothfuss O, Frick JS, Morimatsu M, Schmitz I, Roth J, Ehrchen JM, Essmann F, Schulze-Osthoff K. I kappa B zeta Is a Transcriptional Key Regulator of CCL2/MCP-1.
    Journal of Immunology 190:4812-4820.2013.
  6. Holzinger D, Becker H, Jacobi AM. Interleukin-1-mediated diseases.
    Internist 54:408-+.2013.
  7. Kneidl J, Mysore V, Geraci J, Tuscherr L, Loffler B, Holzinger D, Roth J, Barczyk K. Soluble CD163 masks fibronectin-binding protein A-mediated inflammatory activation of Staphylococcus aureus infected monocytes.
    Cellular microbiology:in press.2013.
  8. Kolly L, Busso N, von Scheven-Gete A, Bagnoud N, Moix I, Holzinger D, Simon G, Ives A, Guarda G, So A, Morris MA, Hofer M. Periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis syndrome is linked to dysregulated monocyte IL-1 beta production.
    Journal of Allergy and Clinical Immunology 131:1635-1643.2013.
  9. Kuipers MT, Vogl T, Aslami H, Jongsma G, van den Berg E, Vlaar APJ, Roelofs J, Juffermans NP, Schultz MJ, van der Poll T, Roth J, Wieland CW. High Levels of S100A8/A9 Proteins Aggravate Ventilator-Induced Lung Injury via TLR4 Signaling.
    Plos One 8.2013.
  10. Moncrieffe H, Ursu S, Holzinger D, Patrick F, Kassoumeri L, Wade A, Roth J, Wedderburn LR. A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8/14 protein.
    Rheumatology 52:1467-1476.2013.
  11. Petersen B, Wolf M, Austermann J, van Lent P, Foell D, Ahlmann M, Kupas V, Loser K, Sorg C, Roth J, Vogl T. The alarmin Mrp8/14 as regulator of the adaptive immune response during allergic contact dermatitis.
    The EMBO journal 32:100-111.2013.
  12. Poti F, Gualtieri F, Sacchi S, Weissen-Plenz G, Varga G, Brodde M, Weber C, Simoni M, Nofer JR. KRP-203, Sphingosine 1-Phosphate Receptor Type 1 Agonist, Ameliorates Atherosclerosis in LDL-R-/- Mice.
    Arteriosclerosis Thrombosis and Vascular Biology 33:1505-1512.2013.
  13. Ramachandran IR, Martner A, Pisklakova A, Condamine T, Chase T, Vogl T, Roth J, Gabrilovich D, Nefedova Y. Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow.
    Journal of Immunology 190:3815-3823.2013.
  14. Verjans E, Ohl K, Yu Y, Lippe R, Schippers A, Wiener A, Roth J, Wagner N, Uhlig S, Tenbrock K, Martin C. Overexpression of CREM alpha in T Cells Aggravates Lipopolysaccharide-Induced Acute Lung Injury.
    Journal of Immunology 191:1316-1323.2013.
  15. Wieland CW, Vogl T, Ordelman A, Vloedgraven HGM, Verwoolde LHA, Rensen JM, Roth J, Boer J, Hessels J. Myeloid marker S100A8/A9 and lymphocyte marker, soluble interleukin 2 receptor: biomarkers of hidradenitis suppurativa disease activity?
    British Journal of Dermatology 168:1252-1258.2013.